Dev Prasad
Analyst, Lucid Capital Markets
Replay available
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) Q4 2025 earnings conference call, held 2026-03-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Serge Belanger
Analyst, Needham & Company
Unknown Participant
Participant
John Kirby
Interim Chief Financial Officer
Chris Chapman
Chief Commercial Officer
Kemp Dolliver
Analyst, Brookline Capital Markets
Ram Selvaraju
Analyst, HC Wainwright
David Zawitz
Chief Operating Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Verrica Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.878 Good morning, ladies and gentlemen, and welcome to the Verica Pharmaceuticals' fourth 00:00:04.878 -- 00:00:07.622 quarter and year-end 2025 00:00:07.622 -- 00:00:10.626 Corporate Update Conference Call. 00:00:10.626 -- 00:00:15.153 At this time, all participants are in a listen-only mode. 00:00:15.153 -- 00:00:20.020 After the speaker's remarks, there will be a question-and-answer session. 00:00:20.020 -- 00:00:22.784 As a reminder, this conference is being recorded. 00:00:22.784 -- 00:00:27.891 I will now turn the call over to our host, Kevin Gardner, of 00:00:27.891 -- 00:00:32.243 LifeSci Advisors. You may begin your conference. 00:00:32.645 -- 00:00:37.830 Thank you, operator. Hello, everyone, and welcome to Verica Pharmaceutical's 00:00:37.830 -- 00:00:41.233 fourth quarter and year-end 2025 00:00:41.233 -- 00:00:46.838 corporate update conference call. With me on the line this morning are Jason Rieger, 00:00:46.838 -- 00:00:52.524 President and Chief Executive Officer, Noah Rosenberg, Chief Medical Officer, 00:00:52.524 -- 00:00:57.909 John Kirby, Interim Chief Financial Officer, David Zawitz, 00:00:57.909 -- 00:01:03.897 Chief Operating Officer, and Chris Chapman, Chief Commercial Officer. 00:01:03.897 -- 00:01:09.123 As a reminder, during today's call, management will make forward-looking statements. 00:01:09.123 -- 00:01:13.848 These forward-looking statements are based on the company's current expectations 00:01:13.848 -- 00:01:17.172 and involve inherent risks and uncertainties. 00:01:17.172 -- 00:01:22.217 Verica's actual results and the timing of events could differ materially 00:01:22.217 -- 00:01:26.582 from those anticipated in such forward-looking statements. 00:01:26.582 -- 00:01:32.321 Please see Verica's SEC fi...